Study of safety and efficacy of rivaroxaban in patients with atrial fibrillation.
Phase of Trial: Phase IV
Latest Information Update: 03 Aug 2015
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 03 Aug 2015 New trial record
- 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.